Trade BioNTech BNTX

Sell
 Buy

BioNTech live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

BioNTech News

Frances Wang 2025 Jul 07, 16:00

Metaplanet Expands Bitcoin Holdings: Where is MTPLF Stock Expected to Go?

cfd trading crypto stocks
Ghko B 2025 Jul 07, 16:00

AVGO Stock is Trending: Trade Broadcom Inc shares CFDs with markets.com

stocks
Frances Wang 2025 Jul 07, 16:00

Commodity CFD brokers Review 2025: AvaTrade, OANDA, Pepperstone and more

commodity cfd trading
Ghko B 2025 Jul 07, 16:00

Index CFDs Trading: How to trade Nasdaq 100 Index CFDs with markets.com?

indices
Ghko B 2025 Jul 06, 16:00

ETF CFD Trading: How to Trade Vanguard S&P 500 ETF (VOO) CFD?

etfs
Tommy Yap 2025 Mar 04, 16:00

Week Ahead: U.S. Inflation Data and BoC Policy Rate in Focus

Forex Indices
Moderna Share Price
Georgy Istigechev 2024 Jan 03, 08:01

Moderna share price jumps as Oppenheimer upgrades stock

Shares
Pfizer shares sink as revenue prospects
Georgy Istigechev 2023 Dec 14, 05:13

Pfizer shares sink on lower COVID revenue prospects

Shares
shutterstock_1781525795.jpg
Zachariah Walker 2023 Feb 14, 09:11

5 Stocks to Fall in Love with this Valentines Day

2021 Aug 24, 08:05

Stocks make further gains as oil bounce carries on

Latest news

Show more
Tommy Yap 2025 Jul 07, 16:00

Morning Note: RBA Holds Rates; Trump Tariffs Hit; Tesla Dips on Musk News

Morning Note Stocks Central Banks
Frances Wang 2025 Jul 06, 16:00

Stock market today: Dow, S&P 500, Nasdaq futures fall, Sensex, Nifty update

Stocks Indices
Frances Wang 2025 Jul 06, 16:00

Lumber Stocks to Watch: SSD stock, UFPI stock, HD stock

Stocks
Frances Wang 2025 Jul 06, 16:00

Oil Price Is Under $70: Where is Oil Price Expected to Go?

Commodities
Tommy Yap 2025 Jul 06, 16:00

Morning Note: Dollar Near Lows on Tariffs; US Eyes AI Chip Curbs; Ethereum’s Future

Morning Note Forex Cryptocurrencies
monetary Policy
Tommy Yap 2025 Jul 05, 21:00

Week Ahead: Monetary Policy Focus Turns to RBA and RBNZ

Forex Indices
Ghko B 2025 Jul 03, 16:00

Solana Price Gains 4%: What is the price target for Solana?

Cryptocurrencies
Frances Wang 2025 Jul 03, 16:00

Bitcoin Price Outlook: What will be the value of Bitcoin in 2025?

Cryptocurrencies

Info

Spread

0.7300

Spread (%)

0.6559 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Wednesday

13:31 - 19:59

Monday

13:31-19:59

Tuesday

13:31-19:59

Thursday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

26455472128

Shares Outstanding

240395008

Earnings Date (Next)

0000-00-00

Div Yield

2022-06-17

Ex-Dividend Date

2022-06-02

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-3.75

Learn more about this instrument

BioNTech BioNTech SE
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany. The company develops BNT111, which is in Phase 2 clinical trial for advance melanoma; BNT113, which is in Phase 2 clinical trial to treat head and neck squamous cell carcinoma; BNT116, which is in Phase I clinical trial for non-small cell lung cancer; BNT142, which is in phase 1/2 clinical trial for multiple solid tumors; BNT151, which is in phase 1/2 clinical trial for solid tumors; BNT152+BNT153, which is in phase 1 clinical trial for solid tumors; and BNT122/RO7198457, which is in Phase 2 clinical trial to treat adjuvant high-risk muscle-invasive urothelial carcinoma, colorectal cancer, pancreatic ductal adenocarcinoma, advance melanoma, as well as in phase 1a/1b clinical trial for advanced/metastatic solid tumors. It also develops BNT211, which is in phase 1 clinical trial to treat CLDN6+ solid tumors; BNT221, phase 1 clinical trial for the treatment of cancer; BNT311/GEN1046 (acasunlimab), which is in phase 3 clinical trial for solid tumors; BNT312/GEN1042, which is in phase 1/2 and 1 clinical trial to treat solid tumors; BNT314/GEN1059, which is in Phase 1/2 clinical trial for advanced or metastatic solid tumors; BNT315/GEN1055, which is in phase 1/2 clinical trial for advanced solid tumors; BNT317, which is in phase 1 clinical trial for advanced solid tumors; BNT327, which is in phase 1/2, 2, and 3 clinical trial to treat small cell lung cancer, advanced/metastatic tnbc, neuroendocrine neoplasm, malignant mesothelioma, EGFR-mutant non-squamous, hepatocellular carcinoma, and advanced solid tumors; and BNT316/ONC-392, which is in phase 1/2, 2, and 3 clinical trial to treat metastatic, non-small cell lung cancer, platinum-resistant ovarian cancer, metastatic castration resistant prostate cancer, and advanced or metastatic solid tumor. BioNTech SE was incorporated in 2008 and is headquartered in Mainz, Germany.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Frances Wang 2025 Jul 07, 16:00

MCD Stock Analysis: What’s Going on with McDonald's Corporation?

Shares Stocks
Ghko B 2025 Jul 07, 16:00

Biotech Stock Analysis: MBIO Soars after FDA Grants Orphan Drug Designation

Stocks
Ghko B 2025 Jul 07, 16:00

Dow Sheds More Than 400 Points: Why Is the Stock Market Down Today?

Stocks
Trustpilot